- 1.Introducing The Psychedelic News Feed Podcast (psychedelicalpha.com)
- 2.Field Notes #5: ‘Psychedelics Week’ in Washington D.C. (psychedelicalpha.com)
- 3.‘Move Fast, with Precision’: Notes from ARPA-H’s Ibogaine Workshop (psychedelicalpha.com)
- 5.Approvals to Access: A Crude Schematic (psychedelicalpha.com)
- 6.Pα+ Library: Psychedelic REMS (psychedelicalpha.com)
- 8.A Closer Look at Definium’s Phase 3 LSD for GAD Readout (psychedelicalpha.com)
- 11.Paving the Way: Husseini Manji on Spravato’s Lessons for Psychedelic Drug Development (psychedelicalpha.com)
- 12.The Psychedelic Practitioner Issue 6: Preparedness (People) (psychedelicalpha.com)
- 13.Smooth Sailing: Definium’s LSD Voyage Hits Primary and Key Secondary Endpoints in GAD (psychedelicalpha.com)
- 15.From Sonora to Big Pharma: Kimon de Greef Traces the Strange Rise of 5-MeO-DMT (psychedelicalpha.com)
- 16.Psychedelic Alpha Crossword: Summer 2026 (psychedelicalpha.com)
- 17.
- 18.Q1 2026: Oregon Psilocybin Services Update (psychedelicalpha.com)
- 19.Psychedelic Funding Update: Q2 2026 (psychedelicalpha.com)
- 20.Field Notes #3: Washington’s Busy Week, and the Biggest Psychedelic Buyout Yet (psychedelicalpha.com)
- 21.
- 22.Compass Closes Out Phase 3 With 6-Month COMP006 Data, Eyes H1’27 Launch (psychedelicalpha.com)
- 24.
- 27.‘A Sea Change’, With Caveats: A Closer Look at Definium’s Phase 3 LSD for MDD Readout (psychedelicalpha.com)
- 28.The Psychedelic Renaissance Has a New Owner: Big Pharma (chacruna.net)
- 29.Breaking: Definium Lands Positive Phase 3, LSD Candidate Shows Strong Antidepressant Effect (psychedelicalpha.com)
- 30.The Psychedelic Practitioner Issue 5: Groups in Practice (psychedelicalpha.com)